Abstract
In Gaucher disease the membrane-associated lysosomal enzyme glucocerebrosidase is deficient (1). Three clinical phenotypes of Gaucher disease are discriminated: type 1, the adult non-neuronopathic form, type 2, the infantile neuronopathic form and type 3, the juvenile neuronopathic form (1). In all phenotypes of the disease there is usually a massive accumulation of lipid in the spleen, and so-called Gaucher cells (macrophages with a characteristic morphology) are abundant in bone marrow, lymph nodes, spleen and liver (1). In all phenotypes, the deficiency of glucocerebrosidase is found in all tissues and also in cultured cells. The disease has a high incidence in certain population groups, representing one of the more frequently occurring genetic diseases (1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brady, R.O., Barranger, J.A. (1983) Glucosylceramide lipidosis: Gaucher’s disease, in: The Metabolic Basis of Inherited Diseases, Stanbury, J.B., Wijngaarden, J.B., Frederickson, D.S., Goldstein, J.L., Brown, M.S., eds.) McGraw-Hill, New York, 842–856.
Erickson, A.H., Ginns, E.I., Barranger, J.A. (1985) Biosynthesis of the lysosomal enzyme glucocerebrosidase, J. Biol. Chem. 260, 14319–14324.
Jonsson, L.M.V., Murray, G.J., Sorrell, S., Strijland, A., Aerts, J.M.F.G., Ginns, E.I., Barranger, J.A., Tager, J.M., and Schram, A.W. (1987) Biosynthesis and maturation of glucocerebrosidase in Gaucher fibroblasts, Eur. J. Biochem. 164, 171–179.
Aerts, J.M.F.G., Brul, S., Donker-Koopman, W.E., Van Weely, S., Murray, G.J., Barranger, J.A., Tager, J.M., and Schram, A.W. (1986) Efficient routing of glucocerebrosidase to lysosomes requires complex oligosaccharide chain formation, Biochem. Biophys. Res. Commun. 141, 452–458.
Ginns, E.I., Brady, R.O., Pirrucello, S., Moore, C., Sorrell, S., Furbish, F.S., Murray, G.J., Tager, J.M., and Barranger, J.A., (1982) Mutations of glucocerebrosidase: Discrimination of neurologic and non-neurologic phenotypes of Gaucher disease, Proc. Natl. Acad. Sci. U.S.A. 79, 5607–5610.
Fabbro, D., Desnick, R.J., and Grabowski, G.A. (1987) Gaucher disease: genetic heterogeneity within and among the subtypes detected by immunoblotting, Am. J. Hum. Genet. 40, 15–31.
Goldblatt, J., and Beighton, P., (1982) South African variants of Gaucher’s disease, in: Gaucher’s Disease: A century of Delineation and Research, Desnick, R.J., Gatt, S., and Grabowski, G.A., eds.) Liss, New York, pp. 95–106
Aerts, J.M.F.G., Donker-Koopman, W.E., Murray, G.J., Barranger, J.A., Tager, J.M., and Schram, A.W. (1986) A procedure for the rapid purification in high yield of human glucocerebrosidase using immuno-affinity chromatography with monoclonal antibodies, Anal. Biochem. 154, 655–663.
Willemsen, R., Van Dongen, J.M., Ginns, E.I., Sips, H.J., Schram, A.W., Tager, J.M., Barranger, J.A., and Reuser, A.J.J. (1987) Ultrastuctural localization of glucocerebrosidase in cultured Gaucher’s disease fibroblasts by immunocytochemistry. J. Neurol. 234, 44–51
Grabowski, G.A;, Dinur, T., Osiecki, K.M., Kruse, J.R., Legier, G.,and Gatt, S. (1985) Gaucher disease type 1,2 and 3: Differential mutations of the acid β-glucosidase active site identified with condutirol β-epoxide derivatives and sphingosine, Am. J. Hum. Genet. 37, 499–510
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Plenum Press, New York
About this paper
Cite this paper
Van Weely, S. et al. (1988). Molecular Properties of Lysosomal Glucocerebrosidase. In: Salvayre, R., Douste-Blazy, L., Gatt, S. (eds) Lipid Storage Disorders. NATO ASI Series, vol 150. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1029-7_5
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1029-7_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8300-3
Online ISBN: 978-1-4613-1029-7
eBook Packages: Springer Book Archive